Table 2.
Multivariate logistic model for the change in the association between marijuana use and DM (total and by age group) (N=8127)
Outcome: DM | Total | Age group 41–59 years | Age group 20–40 years |
Model | OR (95% CI) | OR (95% CI) | OR (95% CI) |
Unadjusted | 0.42 (0.33 to 0.55)* | 0.51 (0.36 to 0.73)* | 0.74 (0.48 to 1.14) |
Model 1: adjusted for social variables | 0.31 (0.20 to 0.48)* | 0.34 (0.20 to 0.59)* | 0.80 (0.43 to 1.50) |
Model 2: adjusted for social variables and laboratory variables | 0.33 (0.22 to 0.50)* | 0.35 (0.21 to 0.61)* | 0.87 (0.47 to 1.63) |
Model 3: adjusted for social variables, laboratory variables and inflammatory marker | 0.36 (0.24 to 0.54)* | 0.37 (0.21 to 0.63)* | 0.95 (0.50 to 1.78) |
Model 4: adjusted for social variables, laboratory variables, inflammatory marker and comorbidity | 0.36 (0.24 to 0.55)* | 0.37 (0.22 to 0.62)* | 0.93 (0.51 to 1.70) |
OR for having DM among marijuana users compared to non-users and 95% CI.
Social variables: race/ethnicity, physical activity, alcohol use, interaction of alcohol and marijuana use and body mass index.
Laboratory variables: total cholesterol and triglyceride.
Inflammatory marker: C reactive protein.
Comorbidity: hypertension.
p<0.0001 compared to non-marijuana users.